Global Perphenazine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Perphenazine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
Perphenazine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Perphenazine market is projected to reach US$ 123.2 million in 2034, increasing from US$ 97.8 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Psychosis and Antiemetic are the major drivers for the industry.
Global Perphenazine key players include Teva, Sandoz, Endo, Mylan, ZHPHARMA etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Asia-Pacific and Europe, both have a share over 20% percent.
In terms of product, Oral Forms is the largest segment, with a share over 90%. And in terms of application, the largest application is Psychosis followed by Antiemetic.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Perphenazine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
Segment by Type
Oral Forms
Injectable Solution
Psychosis
Antiemetic
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Perphenazine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Perphenazine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Perphenazine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Perphenazine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Perphenazine introduction, etc. Perphenazine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Perphenazine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Perphenazine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Perphenazine market is projected to reach US$ 123.2 million in 2034, increasing from US$ 97.8 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Psychosis and Antiemetic are the major drivers for the industry.
Global Perphenazine key players include Teva, Sandoz, Endo, Mylan, ZHPHARMA etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Asia-Pacific and Europe, both have a share over 20% percent.
In terms of product, Oral Forms is the largest segment, with a share over 90%. And in terms of application, the largest application is Psychosis followed by Antiemetic.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Perphenazine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
Segment by Type
Oral Forms
Injectable Solution
Segment by Application
Psychosis
Antiemetic
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Perphenazine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Perphenazine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Perphenazine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Perphenazine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Perphenazine introduction, etc. Perphenazine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Perphenazine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices